For laboratory and research use only. Not for human or animal consumption. Sold to qualified researchers and licensed laboratories.
HomeShopNootropics & Neuro › Selank
Selank 10 mg research peptide vial with lot SEL-2609-Y label
Nootropics & Neuro · SKU S-10

Selank 10 mg

Tuftsin analogue studied for anxiolytic and neuroimmune signalling.

$ 65 per 10 mg vial · free shipping over $300

In stock · ships same day on orders before 2pm ET

Purity (HPLC-UV)≥99.0% on lot SEL-2609-Y
IdentityConfirmed by LC-MS
FormLyophilized powder, sealed vial
Endotoxin< 0.5 EU/mg (LAL)
Storage-20°C sealed · 2-8°C reconstituted
CAS number129954-34-3
Molecular formulaC33H57N11O9
Molecular weight751.9 g/mol
Residues7
Volume pricing, applied automatically in the cart
QuantityPer unitYou save
3 to 4 units$60.457%
5 to 9 units$57.8511%
10+ units$54.6016%

Verify lot SEL-2609-Y in the COA library · This month's lot report

Ships same day on orders before 2pm ET. For laboratory research use only. Not for human or animal consumption.

Frequently bought together

Supplies researchers add to this order

Reconstitution kit
Reconstitution kitKit · $49.99

What is Selank?

Selank is a synthetic analogue of tuftsin, the immunomodulatory tetrapeptide fragment of IgG, extended with the same proline-glycine-proline stabilising tail used in Semax. It is studied for anxiolytic and neuroimmune signalling. Pepstral supplies it as a lyophilized powder for in-vitro laboratory research only.

What is Selank studied for?

  • Tuftsin receptor and neuroimmune assays
  • Anxiolytic behavioural models
  • GABAergic signalling research
  • Comparisons against benzodiazepine reference compounds

All applications above are in-vitro or preclinical research contexts. Selank is sold for laboratory research only and is not for human or animal use.

What does the certificate for lot SEL-2609-Y show?

Every lot of Selank is tested by an independent US laboratory before it is listed. The report for lot SEL-2609-Y is in the COA library and the lot number printed on the vial matches it. The current results:

TestMethodLot SEL-2609-Y result
IdentityLC-MSMatches the calculated mass for the sequence
PurityHPLC-UV, 220 nm99.0%
Net peptide contentAmino acid analysisStated per vial on the certificate
EndotoxinLAL, chromogenic< 0.5 EU/mg
SterilityUSP <71>Pass

How is Selank handled and stored?

Sealed vials are stored at -20°C away from light and keep for 24 months. To reconstitute, add bacteriostatic water slowly down the inside wall of the vial and swirl until clear; never shake. Once in solution, keep at 2 to 8°C and use within the 28-day window on the certificate. The reconstitution guide covers volumes and syringe units and the concentration table gives the numbers for this vial.

Frequently asked questions

What is tuftsin?

A four-residue fragment of the IgG heavy chain with described immunomodulatory activity. Selank is a stabilised analogue of it.

Is Selank related to Semax?

Only by design approach: both are short peptides extended with a PGP tail for stability. Their parent sequences and targets differ.

Is Selank for human use?

No. Every product on this site is sold for in-vitro laboratory research only and is not for human or animal consumption, diagnostic or therapeutic use.

Related

More in Nootropics & Neuro

Semax 10 mg research peptide vial

Semax

Nootropics & Neuro · 10 mg
≥99.0% purity · COA lot SEM-2609-X
from$65
P-21 5 mg research peptide vial

P-21

Nootropics & Neuro · 5 mg
≥99.0% purity · COA lot P21-2609-X
from$120
PE-22-28 10 mg research peptide vial

PE-22-28

Nootropics & Neuro · 10 mg
≥99.0% purity · COA lot PE2-2609-X
from$70
Dihexa 5 mg research peptide vial

Dihexa

Nootropics & Neuro · 5 mg
≥99.0% purity · COA lot DIH-2609-X
from$140Sold out
COA on every lotPublished before listing
≥99% purityHPLC and LC-MS verified
Same-day shippingOrders before 2pm ET
Secure checkout256-bit encrypted
USA-basedSynthesized and shipped domestically
Discreet packagingPlain box, no product names

Restock alerts and new lot reports, by email

One email when a new certificate is published, when a sold-out compound is back, or when a new compound is added. About twice a month, nothing else.